HomeADCT • NYSE
add
ADC Therapeutics SA
Previous close
$4.60
Day range
$2.94 - $4.55
Year range
$1.05 - $4.80
Market cap
434.19M USD
Avg Volume
729.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 16.43M | -11.03% |
Operating expense | 19.01M | -8.03% |
Net income | -40.97M | 6.83% |
Net profit margin | -249.38 | -4.72% |
Earnings per share | — | — |
EBITDA | -30.59M | 13.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 234.74M | -14.41% |
Total assets | 289.76M | -16.99% |
Total liabilities | 527.94M | 1.33% |
Total equity | -238.18M | — |
Shares outstanding | 123.88M | — |
Price to book | -2.18 | — |
Return on assets | -25.02% | — |
Return on capital | -32.49% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -40.97M | 6.83% |
Cash from operations | -29.63M | -18.32% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -198.00K | 77.47% |
Net change in cash | -29.82M | -15.38% |
Free cash flow | -24.55M | 9.91% |
About
Founded
2011
Website
Employees
264
